摘要
骨健灵是我院研制的一种含钙性复方散剂，用于小儿骨化醇缺乏性佝偻病防治，本实验采用模型动物治疗观察法，发现观察指标治疗组与对照组差别显著（P＜0.05），实验治疗效果可靠，对骨健灵进一步开展临床研究有指导意义。
Gujianling is a compoupd medicinal powder developed in our hospital. It is mainly
used in prevention and treatment of richets because of the lack of cholecaliferol. Sa-
fisfactory therapeutical results have been demonstrated in the clinical trial. It showed
that differences of the values of observation indices before and treatment were significant
(p>0.05) and the improvement of clinical symptoms were obvious. This proved that
Gujianling possesses good therapeutical basis for its pharmacodynamics and possesses an
importance guiding meaning for further clinical studies and its clinical application.
出处
《重庆医药》
CSCD
1990年第1期4-6,共3页
关键词
佝偻病
血清碱性磷酸酶
血清磷
胫骨钙线
胫骨干骺端X光片
richets serum alkaline phosphatase (AKP) serum phosphorus (P),provisional calcified zone X-ray of melaphysis
